ArticleBioorganic & medicinal chemistry2014

Methyl-substituted conformationally constrained rexinoid agonists for the retinoid X receptors demonstrate improved efficacy for cancer therapy and prevention.

Anil Desphande et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.